theophylline has been researched along with antofloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, N; Liu, L; Liu, X; Pan, X; Wang, G; Wang, P; Xie, L | 1 |
| Cheng, JL; Fan, HW; Liu, HY; Liu, L; Liu, XD; Pan, X; Xiao, DW; Xie, L; Yang, HW | 1 |
1 trial(s) available for theophylline and antofloxacin
| Article | Year |
|---|---|
Modulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans.
Topics: Adult; Anti-Bacterial Agents; Bronchodilator Agents; Cross-Over Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Interactions; Female; Humans; Male; Microsomes, Liver; Ofloxacin; Theophylline; Young Adult | 2011 |
1 other study(ies) available for theophylline and antofloxacin
| Article | Year |
|---|---|
A physiologically based pharmacokinetic model characterizing mechanism-based inhibition of CYP1A2 for predicting theophylline/antofloxacin interaction in both rats and humans.
Topics: Animals; Area Under Curve; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Interactions; Fluoroquinolones; Humans; Liver; Male; Microsomes, Liver; Models, Animal; Models, Theoretical; Ofloxacin; Phosphodiesterase Inhibitors; Rats; Theophylline | 2011 |